top of page


Respiratory syncytial virus | News | Updates | iPharmaCenter
ExpressScripts is optimistic about the RSV season with the approval of new vaccines In May 2023, the U.S. Food & Drug Administration...


HPV News | Updates | iPharmaCenter
Merck has released a comprehensive publication on the long-term follow-up (LTFU) data for Gardasil 9 (Human Papillomavirus 9-valent...
Meningococcal infection | iPharmaCenter
GlaxoSmithKline (GSK) has presented positive results from the phase III trial of its MenABCWY vaccine candidate at the European Society...


HIV News and media blogs | Viiv's Apretude approved in the US for HIV prevention
Janssen to discontinue HIV vaccine Phase 3 trial. Janssen Pharmaceuticals and Global Partners announced their intention to discontinue...
bottom of page